| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $153.7M | +126.8% |
| R&D Expense | $180.4M | +31.5% |
| SG&A Expense | $62.6M | +5.1% |
| Operating Income | -$89.3M | +30.8% |
| Interest Expense | $1.3M | -45.8% |
| Pre-tax Income | -$88.6M | +24.1% |
| Income Tax | $18.2M | +627.7% |
| Net Income | -$106.8M | +10.4% |
| EPS (Basic) | -$1.78 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.3M | +46.6% |
| Short-term Investments | $264.4M | +3.7% |
| Accounts Receivable | $36.1M | +406.6% |
| Current Assets | $421.5M | +19.4% |
| Total Assets | $470.7M | +15.7% |
| Current Liabilities | $93.7M | +40.9% |
| Long-term Debt | $4.1M | -75.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$111.6M | -3245.0% |
| Investing Cash Flow | -$3.9M | +88.8% |
| Financing Cash Flow | $137.6M | +184.7% |
| +24.3% |
| EPS (Diluted) | -$1.78 | +24.3% |
| Total Liabilities |
| $321.1M |
| +69.1% |
| Stockholders' Equity | $149.6M | -31.1% |